Treatments that inhibit TRAP1 by interacting with an allosteric pocket, such as honokiol bis-dichloroacetate, have been shown to reverse TRAP1 effects in cancer cells, subsequently decreasing proliferation and tumorigenic growth while restoring ROS levels and SDH function [41,136]. The gene discussed is TRAP1; the disease is cancer.